HCQS-200 Tablet is primarily used to treat autoimmune disorders such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and polymorphous light eruption. It also helps manage skin conditions triggered by sun exposure, especially those linked to autoimmune diseases. Additionally, HCQS-200 is effective in the treatment and prevention of certain types of malaria. In some cases, it may be used as an adjunct therapy in type 2 diabetes to improve blood sugar control, though this use is considered off-label and should be guided by a physician.
HCQS 200 Tablet contains Hydroxychloroquine, an anti-inflammatory drug which improves insulin sensitivity in diabetes, acts as a mild immunosuppressant for rheumatoid arthritis, reduces skin lesions in lupus, and kills malaria parasites by increasing toxic compounds within them.
























































































